bf/NASDAQ:HALO_icon.jpeg

COM:HALOZYME

Halozyme Therapeutics, Inc.

  • Stock

USD

Last Close

45.70

22/11 21:00

Market Cap

6.74B

Beta: -

Volume Today

4.55M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-83.48M
-
-68.38M
18.09%
-32.23M
52.86%
-103.02M
219.64%
62.97M
161.12%
-80.33M
227.57%
-72.24M
10.07%
129.09M
278.69%
402.71M
211.97%
202.13M
49.81%
281.59M
39.31%
depreciation and amortization
1.23M
-
1.76M
43.61%
1.68M
4.82%
2.41M
43.71%
2.16M
10.33%
2.39M
10.50%
4.07M
70.35%
3.28M
19.27%
3.00M
8.74%
49.64M
1,556.36%
84.86M
70.94%
deferred income tax
1.12M
-
1.69M
51.48%
887K
47.51%
560K
36.87%
-257K
145.89%
-3.08M
1,100.39%
490K
115.88%
644K
31.43%
-155.43M
24,235.71%
40.01M
125.74%
34.51M
13.75%
stock based compensation
9.54M
-
15.27M
60.14%
20.84M
36.43%
25.59M
22.78%
30.67M
19.87%
35.70M
16.39%
34.78M
2.58%
17.20M
50.53%
20.82M
21.02%
24.40M
17.18%
36.62M
50.10%
change in working capital
22.10M
-
106K
99.52%
-29.50M
27,927.36%
16.98M
157.56%
20.69M
21.85%
-5.87M
128.35%
-50.54M
761.56%
-108.37M
114.42%
3.74M
103.45%
-85.95M
2,399.38%
-38.67M
55.01%
accounts receivables
6.61M
-
-52K
100.79%
-23.26M
44,632.69%
16.73M
171.92%
-6.45M
138.57%
11.61M
279.96%
-29.44M
353.48%
-38.29M
30.07%
6.75M
117.64%
-83.94M
1,342.65%
-3.34M
96.02%
inventory
-3.50M
-
-236K
93.26%
-3.08M
1,206.36%
-5.13M
66.53%
9.48M
284.59%
-17.48M
284.45%
-6.73M
61.48%
-31.39M
366.11%
7.37M
123.48%
-17.48M
337.16%
-26.88M
53.79%
accounts payables
7.89B
-
-816K
100.01%
13.87M
1,799.26%
-244K
101.76%
15.63M
6,505.33%
-278.49M
1,881.86%
4.64M
101.67%
-41.21M
988.49%
1.17M
102.83%
24.54M
2,002.40%
-12.55M
151.14%
other working capital
-7.87B
-
1.21M
100.02%
-17.02M
1,506.53%
5.63M
133.06%
2.04M
63.83%
278.49M
13,584.91%
-19.01M
106.82%
2.52M
113.25%
-11.55M
558.90%
-9.06M
21.56%
4.10M
145.21%
other non cash items
155.81K
-
2.02M
1,199.67%
1.24M
38.62%
7.11M
471.76%
17.82M
150.74%
1.70M
90.48%
-1.98M
216.56%
13.60M
787.71%
24.61M
80.91%
9.89M
59.82%
-10.33M
204.50%
net cash provided by operating activities
-49.34M
-
-47.52M
3.69%
-37.08M
21.96%
-50.38M
35.87%
134.05M
366.07%
-49.50M
136.93%
-85.42M
72.57%
55.45M
164.92%
299.44M
439.98%
240.11M
19.81%
388.57M
61.83%
investments in property plant and equipment
-2.30M
-
-1.37M
40.46%
-2.36M
72.51%
-3.14M
32.92%
-1.35M
56.97%
-4.66M
245.41%
-4.04M
13.36%
-2.50M
38.02%
-1.46M
41.81%
-4.81M
230.13%
-15.29M
217.96%
acquisitions net
1.51M
-
1.08M
28.69%
404.83M
37,523.79%
-999.12M
346.80%
purchases of investments
-48.95M
-
-88.88M
81.59%
-71.48M
19.58%
-155.41M
117.41%
-398.19M
156.21%
-311.11M
21.87%
-389.76M
25.28%
-226.19M
41.97%
-652.51M
188.49%
-255.21M
60.89%
-292.91M
14.77%
sales maturities of investments
3.38M
-
57.30M
1,597.81%
79.73M
39.14%
81.78M
2.57%
235.81M
188.33%
318.27M
34.97%
388.25M
21.99%
305.97M
21.19%
247.68M
19.05%
746.13M
201.24%
211.30M
71.68%
other investing activites
-1.51M
-
-404.83M
-
26.01M
106.42%
net cash used for investing activites
-47.87M
-
-32.95M
31.16%
5.89M
117.87%
-76.77M
1,403.77%
-163.73M
113.29%
2.49M
101.52%
-5.55M
322.58%
78.35M
1,512.04%
-406.29M
618.53%
-487.00M
19.87%
-96.91M
80.10%
debt repayment
-54.25M
-
-15.99M
70.52%
-77.52M
384.63%
-108.08M
39.43%
-19.56M
81.90%
-369.06M
1,786.83%
-447.45M
21.24%
-13.48M
96.99%
common stock issued
5.08B
-
107.71M
97.88%
13.10M
87.84%
1.86M
85.76%
134.87M
7,131.85%
13.72M
89.83%
14.22M
3.68%
63.39M
345.68%
12.54M
80.22%
14.05M
12.08%
7.88M
43.92%
common stock repurchased
-200.00M
-
-150.12M
24.94%
-350.06M
133.19%
-200.00M
42.87%
-402.38M
101.19%
dividends paid
-14.22M
-
-63.39M
345.68%
-12.54M
80.22%
-13.48M
-
other financing activites
-5.05B
-
6.79M
100.13%
203.01M
-
12.78M
93.71%
461.30M
-
63.39M
86.26%
796.99M
1,157.22%
995.78M
24.94%
13.48M
98.65%
net cash used provided by financing activities
25.06M
-
114.50M
356.83%
13.10M
88.56%
150.62M
1,049.95%
131.66M
12.59%
-63.80M
148.46%
153.22M
340.16%
-106.28M
169.37%
77.86M
173.26%
362.37M
365.38%
-407.99M
212.59%
effect of forex changes on cash
net change in cash
-72.14M
-
34.03M
147.17%
-18.10M
153.18%
23.47M
229.70%
101.98M
334.46%
-110.80M
208.66%
62.24M
156.17%
27.52M
55.78%
-28.98M
205.30%
115.48M
498.41%
-116.33M
200.74%
cash at beginning of period
99.50M
-
27.36M
72.51%
61.39M
124.40%
43.29M
29.48%
67.26M
55.37%
169.24M
151.61%
58.44M
65.47%
120.68M
106.51%
148.20M
22.81%
119.22M
19.56%
234.69M
96.86%
cash at end of period
27.36M
-
61.39M
124.40%
43.29M
29.48%
66.76M
54.22%
169.24M
153.49%
58.44M
65.47%
120.68M
106.51%
148.20M
22.81%
119.22M
19.56%
234.69M
96.86%
118.37M
49.56%
operating cash flow
-49.34M
-
-47.52M
3.69%
-37.08M
21.96%
-50.38M
35.87%
134.05M
366.07%
-49.50M
136.93%
-85.42M
72.57%
55.45M
164.92%
299.44M
439.98%
240.11M
19.81%
388.57M
61.83%
capital expenditure
-2.30M
-
-1.37M
40.46%
-2.36M
72.51%
-3.14M
32.92%
-1.35M
56.97%
-4.66M
245.41%
-4.04M
13.36%
-2.50M
38.02%
-1.46M
41.81%
-4.81M
230.13%
-15.29M
217.96%
free cash flow
-51.64M
-
-48.89M
5.33%
-39.44M
19.32%
-53.52M
35.69%
132.70M
347.95%
-54.16M
140.82%
-89.46M
65.17%
52.95M
159.19%
297.98M
462.76%
235.30M
21.04%
373.28M
58.64%

All numbers in USD (except ratios and percentages)